Rectal Examinations Do Not Improve Prostate Cancer Screening Effectiveness
A new study has found that rectal examination has no advantages over the PSA blood test for detecting prostate cancer.
Read MorePosted by Andy Lundin | Jan 22, 2024 | Prostate |
A new study has found that rectal examination has no advantages over the PSA blood test for detecting prostate cancer.
Read MorePosted by Andy Lundin | Jan 16, 2024 | Lung Cancer |
The epigenomic technology platform predicts and monitors immunotherapy responses for patients with non-small cell lung cancer (NSCLC).
Read MorePosted by Chris Wolski | Jan 12, 2024 | Digital Pathology |
By examining the UK’s technology-centric strategy and response, nations can right-size the practice of pathology and prepare for the future.
Read MorePosted by Andy Lundin | Jan 10, 2024 | Prostate |
Researchers have developed a blood test that can reliably detect NEPC and differentiate it from CRPC-adenocarcinoma.
Read MorePosted by Andy Lundin | Jan 9, 2024 | Cancer, Research |
PanGIA Biotech is preparing to launch new clinical studies in multi-cancer early detection using the PanGIA Liquid Biopsy Platform.
Read More